Case Reports
Transformation from lepromatous to borderline leprosy under clofazimine therapy
- PMID: 1022964
Item in Clipboard
Case Reports
Transformation from lepromatous to borderline leprosy under clofazimine therapy
Lepr India.
1976 Apr.
Abstract
Patients of lepromatous leprosy who have evolved from the borderline type of disease are known to revert to the borderline state through a reactionary phenomenon under anti-leprosy chemotherapy with Dapsone. We present here the case report of a reversal from a reactional lepromatous disease to the borderline type under Clofazimine.
Similar articles
-
Clinical trial with clofazimine in leprosy.Lepr India. 1976 Oct;48(4 Suppl):703-8. Lepr India. 1976. PMID: 1026807
-
Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.Int J Lepr Other Mycobact Dis. 1974 Jul-Sep;42(3):276-88. Int J Lepr Other Mycobact Dis. 1974. PMID: 4617715 No abstract available.
-
Daily multidrug therapy for leprosy; results of a fourteen-year experience.Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44. Int J Lepr Other Mycobact Dis. 1997. PMID: 9207752 Clinical Trial.
-
[Hansen's disease: case report and review of literature].Rev Chilena Infectol. 2008 Feb;25(1):64-9. Epub 2008 Feb 8. Rev Chilena Infectol. 2008. PMID: 18273528 Review. Spanish.
-
[Immuno-allergic accidents with rifamipcin].Acta Leprol. 2001-2002;12(2):71-8. Acta Leprol. 2001. PMID: 12136739 Review. French.
Cited by
-
Study of Dermal Nerve Pathology in Upgrading and Downgrading Type 1 and Type 2 Leprosy Reactions.Am J Trop Med Hyg. 2025 Feb 25;112(5):1081-1086. doi: 10.4269/ajtmh.23-0426. Print 2025 May 7. Am J Trop Med Hyg. 2025. PMID: 39999455